Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Bought by Point72 Asset Management L.P.

Point72 Asset Management L.P. lifted its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 210.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,400 shares of the company’s stock after purchasing an additional 33,507 shares during the period. Point72 Asset Management L.P.’s holdings in Establishment Labs were worth $2,138,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in ESTA. First Turn Management LLC purchased a new position in Establishment Labs during the second quarter worth approximately $16,812,000. Sofinnova Investments Inc. raised its holdings in shares of Establishment Labs by 204.1% during the 2nd quarter. Sofinnova Investments Inc. now owns 429,244 shares of the company’s stock worth $19,505,000 after acquiring an additional 288,082 shares during the period. Divisadero Street Capital Management LP acquired a new position in shares of Establishment Labs during the 2nd quarter valued at about $5,829,000. Millennium Management LLC grew its holdings in shares of Establishment Labs by 49.8% in the second quarter. Millennium Management LLC now owns 273,605 shares of the company’s stock valued at $12,433,000 after purchasing an additional 90,943 shares during the period. Finally, Rice Hall James & Associates LLC increased its position in Establishment Labs by 10.7% during the third quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company’s stock worth $34,326,000 after purchasing an additional 76,959 shares during the last quarter. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Stock Down 1.5 %

Establishment Labs stock opened at $43.27 on Tuesday. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. The firm has a 50 day moving average price of $43.44 and a 200 day moving average price of $44.26. Establishment Labs Holdings Inc. has a fifty-two week low of $22.05 and a fifty-two week high of $60.12. The company has a market capitalization of $1.21 billion, a PE ratio of -16.77 and a beta of 1.16.

Analysts Set New Price Targets

Several research firms have recently weighed in on ESTA. Citigroup increased their price target on shares of Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. BTIG Research increased their price objective on Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Finally, Stephens upgraded Establishment Labs to a “strong-buy” rating in a research report on Monday, December 2nd. One analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $60.60.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.